Participants 60 132 6
adults with soft tissue sarcomas of the head and neck, breast, and trunk
Participants 135 382 11
Since 1977, 31 patients were entered in a randomized, prospective study testing the efficacy of adjuvant chemotherapy after aggressive local treatment of high-grade sarcomas of the head, neck, breast, and trunk (excluding retroperitoneal sarcomas)
Participants 384 508 5
All patients had complete resection of gross tumor and underwent postoperative radiotherapy (6000-6300 rads over 7-8 weeks).
Participants 509 725 3
Seventeen patients received adjuvant chemotherapy consisting of doxorubicin (less than or equal to 550 mg/m2), cyclophosphamide (less than or equal to 5500 mg/m2), and methotrexate (less than or equal to 1000 mg/kg).
Participants 1292 1523 3
An additional 26 patients were treated in an identical fashion, but were not part of the randomized trial because of contraindications to chemotherapy, refusal to enter the randomized trial, or because they were treated before 1977
Participants 1596 1623 4
entire group of 57 patients
Participants 2030 2147 3
The subgroup of patients with sarcomas of the trunk (39 patients) demonstrated the greatest benefit from chemotherapy
